3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
34
Carcinoma, Non-Small-Cell Lung
26
Breast Neoplasms
25
Lung Neoplasms
24
Colonic Neoplasms
18
Head and Neck Neoplasms
16
Rectal Neoplasms
14
Sarcoma
10
Prostatic Neoplasms
10
Neoplasm Metastasis
9
Pancreatic Neoplasms
8
Neoplasms
7
Mouth Neoplasms
7
Melanoma
7
Esophageal Neoplasms
7
Ovarian Neoplasms
6
Glioblastoma
6
Adenomatous Polyposis Coli
6
Precancerous Conditions
5
Neuroblastoma
5
Liver Neoplasms
5
Central Nervous System Neoplasms
5
Carcinoma
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Recurrence
4
Oropharyngeal Neoplasms
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Interventions
Oxaliplatin
6
Irinotecan
5
Fluorouracil
5
Bevacizumab
4
Leucovorin
3
Drug Therapy
3
Capecitabine
3
5,10-methylenetetrahydrofolic acid
3
pembrolizumab
2
Ocoxin
2
Magnetic Resonance Spectroscopy
2
Levoleucovorin
2
Folfox protocol
2
Cyclophosphamide
2
Cetuximab
2
trifluridine tipiracil drug combination
1
sintilimab
1
repotrectinib
1
pralsetinib
1
penpulimab
1
napabucasin
1
huachansu
1
guadecitabine
1
golotimod
1
encorafenib
1
alectinib
1
XELOX
1
Ursodeoxycholic Acid
1
Surveys and Questionnaires
1
S-1 plus cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Gastrointestinal Diseases
×
Celecoxib
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled